Immuno-histological Role of CD133 in Pathogenesis of Gastric Cancer
DOI:
https://doi.org/10.36320/ajb/v15.i3.13271Keywords:
ISSR markers, Keywords: gastric sleeve, thyroid-stimulating hormone, ferritin protein, CBCAbstract
The spread of cancer is one of the biggest obstacles at the present time, which has caused panic to people on the health and psychological level, adding to the economic burdens and human losses at the level of most countries of the world. For this reason, most medical institutions and researchers have shown great interest in this field to find the appropriate way out by finding sincere treatments for this problem.The current study includes a review of the immuno-histological role of the CD133 indicator in the development and severity of stomach cancer in order to be a key for applied studies to employ this indicator in the diagnosis or treatment of gastric cancer.
Downloads
References
Brungs D., Aghmesheh M., Vine K.L., Becker T.M., Carolan M.G., Ranson M. (2016),Gastric cancer stem cells: Evidence, potential markers, and clinical implications. J. Gastroenterol., 51: 313–326. DOI: https://doi.org/10.1007/s00535-015-1125-5
Ishimoto T., Sawayama H., Sugihara H., Baba, H.( 2014) Interaction between gastric cancer stem cells and the tumor microenvironment. J. Gastroenterol., 49: 1111–1120. DOI: https://doi.org/10.1007/s00535-014-0952-0
Katsuno Y., Ehata S., Yashiro M., Yanagihara K., Hirakawa K. Miyazono, K. (2012) Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-beta. J. Pathol., 228: 391–404. DOI: https://doi.org/10.1002/path.4020
Nguyen P.H., Giraud J., Chambonnier L., Dubus P., Wittkop L., Belleannee G., Collet D., Soubeyran I., Evrard S., Rousseau B. (2017),Characterization of Biomarkers of Tumorigenic and Chemoresistant Cancer Stem Cells in Human Gastric Carcinoma. Clin. Cancer Res., 23: 1586–1597. DOI: https://doi.org/10.1158/1078-0432.CCR-15-2157
Liu J., Ma L., Xu J., Liu C., Zhang J., Liu J., Chen R., Zhou Y. (2013)Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties. Int. J. Oncol., 42: 453–459 DOI: https://doi.org/10.3892/ijo.2012.1720
Ohkuma M., Haraguchi N., Ishii H., Mimori K., Tanaka F., Kim H.M., Shimomura M., Hirose H., Yanaga K., Mori M. (2012),Absence of CD71 transferrin receptor characterizes human gastric adenosquamous carcinoma stem cells. Ann. Surg. Oncol., 19: 1357–1364. DOI: https://doi.org/10.1245/s10434-011-1739-7
Fujita T., Chiwaki F., Takahashi R.U., Aoyagi K., Yanagihara K., Nishimura T., Tamaoki M., Komatsu M., Komatsuzaki R., Matsusaki K. (2015I),identification and Characterization of CXCR4-Positive Gastric Cancer Stem Cells. PLoS ONE, 10: e0130808. DOI: https://doi.org/10.1371/journal.pone.0130808
Hashimoto K., Aoyagi K., Isobe T., Kouhuji K., Shirouzu K. (2014),Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer. Gastric Cancer, 17: 97–106. DOI: https://doi.org/10.1007/s10120-013-0255-9
Chen Y.C., Hsu H.S., Chen Y.W., Tsai T.H., How C.K., Wang C.Y. (2008),Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One.,3:e2637. DOI: https://doi.org/10.1371/journal.pone.0002637
Zhao P., Lu Y., Jiang X., Li X. (2011)Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma. Cancer Sci., 102:1107–1111. DOI: https://doi.org/10.1111/j.1349-7006.2011.01894.x
Komohara Y., Takeya M. CAFs and TAMs: (2017),Maestros of the tumour microenvironment. J. Pathol., 241: 313–315. DOI: https://doi.org/10.1002/path.4824
Li X., Bu W., Meng L., Liu X., Wang S., Jiang L., Ren M., Fan Y., Sun H. (2019),CXCL12/CXCR4 pathway orchestrates CSC-like properties by CAF recruited tumor associated macrophage in OSCC. Exp. Cell Res., 378: 131–138. DOI: https://doi.org/10.1016/j.yexcr.2019.03.013
Hasegawa T., Yashiro M., Nishii T., Matsuoka J., Fuyuhiro Y., Morisaki T., Fukuoka T., Shimizu K., Shimizu T., Miwa A. (2014),Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-beta signaling. Int. J. Cancer, 134: 1785–1795. DOI: https://doi.org/10.1002/ijc.28520
Sultan M., Coyle K.M., Vidovic D., Thomas M.L., Gujar S., Marcato P. Hide-and-seek: (2017),The interplay between cancer stem cells and the immune system. Carcinogenesis, 38: 107–118. DOI: https://doi.org/10.1093/carcin/bgw115
Yang Y., Wu K.E., Zhao E., Li W., Shi L., Xie G., Jiang B., Wang Y., Li R., Zhang. (2015),B7-H1 enhances proliferation ability of gastric cancer stem-like cells as a receptor. Oncol. Lett., 9: 1833–1838. DOI: https://doi.org/10.3892/ol.2015.2949
Rezalotfi A., Ahmadian E., Aazami H., Solgi G., Ebrahimi M. (2019),Gastric Cancer Stem Cells Effect on Th17/Treg Balance; A Bench to Beside Perspective. Front. Oncol., 9: 226. DOI: https://doi.org/10.3389/fonc.2019.00226
Hajimoradi M., Mohammad Hassan Z., Ebrahimi M., Soleimani M., Bakhshi M., Firouzi J., Samani F.S. (2016)STAT3 is Overactivated in Gastric Cancer Stem-Like Cells. Cell J., 17: 617–628.
Charalampakis N., Economopoulou P., Kotsantis I., Tolia M., Schizas D., Liakakos T., Elimova E., Ajani J.A. Psyrri, A. Medical management of gastric cancer: A 2017 update. Cancer Med. 2018, 7: 123–133 DOI: https://doi.org/10.1002/cam4.1274
Jang J., Song Y., Kim S., Kim J., Seo H.R. (2017),Potential mechanisms of CD133 in cancer stem cells. Life Sciences., 184: 25-29. DOI: https://doi.org/10.1016/j.lfs.2017.07.008
Norollahi S.E Mansour-Ghanaei F., Joukar F., Ghadarjani S., Mojtahedi K., Gharaei Nejad K., Hemmati H., Gharibpoor F., Khaksar R., Samadani A.A. (2019),Therapeutic approach of Cancer stem cells (CSCs) in gastric adenocarcinoma; DNA methyltransferases enzymes in cancer targeted therapy. Biomed. Pharmacother. Biomed. Pharmacother., 115: 108958. DOI: https://doi.org/10.1016/j.biopha.2019.108958
Zhan, Y.Y.; He, J.P.; Chen, H.Z.; Wang, W.J.; Cai, J.C. (2013),Orphan receptor TR3 is essential for the maintenance of stem-like properties in gastric cancer cells. Cancer Lett., 329, 37–44. DOI: https://doi.org/10.1016/j.canlet.2012.09.022
Fukamachi H, Shimada S, Ito K, Ito Y, Yuasa Y. (2011),CD133 is a marker of gland-forming cells in gastric tumors and ox17 is involved in its regulation. Cancer Sci.;102:1313–1321. DOI: https://doi.org/10.1111/j.1349-7006.2011.01947.x
Tian T., Zhang Y., Wang S., Zhou J., Xu S. (2012),Sox2 enhances the tumorigenicity and chemoresistance of cancer stem-like cells derived from gastric cancer. J. Biomed. Res., 26: 336–345. DOI: https://doi.org/10.7555/JBR.26.20120045
Jiang W., Liu K., Guo Q., Cheng J., Shen L., Cao Y., Wu J., Shi J., Cao H., Liu B., Tao K., Wang G., Cai K. (2017),Tumor-infiltrating immune cells and prognosis in gastric cancer: a systematic review and meta-analysis. Oncotarget.,8(37):62312-62329. DOI: https://doi.org/10.18632/oncotarget.17602
Giraud J., Molina-Castro S., Seeneevassen L., Sifre E., Izotte J., Tiffon C., Staedel C., Boeuf H., Fernandez S., Barthelemy P. (2020),Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells. Int. J. Cancer., 146(8):2255-2267. DOI: https://doi.org/10.1002/ijc.32667
Smith L.M., Nesterova A., Ryan M.C., Duniho S., Jonas M., Anderson M., Zabinski R.F., Sutherland M.K., Gerber H.P., Van Orden K.L. (2008),CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. Br. J. Cancer., 99: 100–109. DOI: https://doi.org/10.1038/sj.bjc.6604437
Wang L, Fan J, Thompson LF, Zhang Y, Shin T, Curiel TJ, Zhang B. (2011),CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice. J Clin Invest., 121(6):2371-82. DOI: https://doi.org/10.1172/JCI45559
Chenn H., Lin J., Shan Y., Zhengmao L. The promotion of nanoparticle delivery to two populations of gastric cancer stem cells by CD133 and CD44 antibodies. Biomed. Pharmacother. Biomed. Pharmacother. 2019, 115: 108857. DOI: https://doi.org/10.1016/j.biopha.2019.108857
Antonioli L., Pacher P., Vizi E.S., Hasko G. (2013).CD39 and CD73 in immunity and inflammation. Trends Mol. Med. 19, 355–367 DOI: https://doi.org/10.1016/j.molmed.2013.03.005
Wang Y., Chen M., Wu Z., Tong C., Dai H., Guo Y., Liu Y., Huang J., Lv H., Luo C. (2018),CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial. Oncoimmunology., 7: e1440169. DOI: https://doi.org/10.1080/2162402X.2018.1440169
Glumac P.M., LeBeau A.M. The role of CD133 in cancer: a concise review. Clin Trans Med. 2018, 7: 18. DOI: https://doi.org/10.1186/s40169-018-0198-1
Soleimani A., Dadjoo P., Avan A., Soleimanpour S., Rajabian M., Ferns G. (2022),Emerging roles of CD133 in the treatment of gastric cancer, a novel stem cellbiomarker and beyond. Life Sci., 293:120050. DOI: https://doi.org/10.1016/j.lfs.2021.120050
O'Brien C.A., Pollett A., Gallinger S., Dick J.E. (2007)A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 445(7123): 106-110, DOI: https://doi.org/10.1038/nature05372
Addeo M., Di Paola G., Verma H.K., Laurino S., Russi S., Zoppoli P. (2021), Gastric cancerstem cells: a glimpse on metabolicreprogramming. Front Oncol. 16;11:698394. DOI: https://doi.org/10.3389/fonc.2021.698394
Rappa G., Fodstad O., Lorico A. (2008),The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells., 26: 3008–3017. DOI: https://doi.org/10.1634/stemcells.2008-0601
Takaishi S., Okumura T., Wang T.C. (2008),Gastric cancer stem cells. J Clin Oncol.,26(17):2876–82. DOI: https://doi.org/10.1200/JCO.2007.15.2603
Wen L, Chen XZ, Yang K, Chen ZX, Zhang B, Chen JP, Zhou ZG, Mo XM, Hu JK. (2013),Prognostic value of cancer stem cell marker CD133 expression in gastric cancer: a systematic review. PLoS One., (3):e59154. DOI: https://doi.org/10.1371/journal.pone.0059154
Park J., Kim S.K., Hallis S.P., Choi B.H., Kwak M.K. (2022),Role of CD133/NRF2 Axis in the Development of Colon Cancer Stem Cell-Like Properties. Front Oncol., 11:808300. DOI: https://doi.org/10.3389/fonc.2021.808300
Ong C.W., Kim L.G., Kong H.H., Low L.Y., Iacopetta B., Soong R., Salto-Tellez M. (2010),CD133 expression predicts for non-response to chemotherapy in colorectal cancer. Mod Pathol., 23(3):450-7. DOI: https://doi.org/10.1038/modpathol.2009.181
Guo R., Yang B. Hypoxia-Induced LXRα Contributes to the Migration and Invasion of Gastric Cancer Cells. Folia Biol (Praha). 2021, 67:91-101. DOI: https://doi.org/10.14712/fb2021067030091
Hang D., Dong H.C., Ning T., Dong B., Hou D.L., Xu W.G. .( 2012),Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma. Dis Esophagus, 25(7):638-44. DOI: https://doi.org/10.1111/j.1442-2050.2011.01298.x
Kim N., Choung H.K., Lee M.J., Khwarg S.I., Kim J.E. . (2015),Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis. Invest Ophthalmol Vis Sci, 56(3):1813-9. DOI: https://doi.org/10.1167/iovs.14-15547
Li F., Zeng H., Ying K. (2011),The combination of stem cell markers CD133 and ABCG2 predicts relapse in stage I non-small cell lung carcinomas. Med Oncol., 28(4):1458-62. DOI: https://doi.org/10.1007/s12032-010-9646-5
Attiaa S., Atwan N., Arafa M., Shahin R.A. (2019),Expression of CD133 as a cancer stem cell marker in invasive gastric carcinoma. Pathologica., 111(1):18-23. DOI: https://doi.org/10.32074/1591-951X-51-18
Zabaleta J. (2012),Multifactorial etiology of gastric cancer. Methods Mol Biol., 863: 411-35. DOI: https://doi.org/10.1007/978-1-61779-612-8_26
Yang P., Zhou Y., Chen B., Wan H.W., Jia G.Q., Bai H.L., Wu X.T. (2009),Overweight, obesity and gastric cancer risk: Results from a meta-analysis of cohort studies. Europ J Cancer. 45(16): 2867-2873. DOI: https://doi.org/10.1016/j.ejca.2009.04.019
Machida-Montani A., Sasazuki S., Inoue M., Natsukawa S., Shaura K., Koizumi Y., Kasuga Y., Hanaoka T., Tsugane S. (2004),Association of Helicobacter pylori infection and environmental factors in non-cardia gastric cancer in Japan. Gastric Cancer., 7(1): 46-53. DOI: https://doi.org/10.1007/s10120-004-0268-5
Walker R., Poleszczuk J., Mejia J., Lee J.K., Pimiento J.M., Malafa M., Giuliano A.R., Enderling H., Coppola D. Toward early detection of Helicobacter pylori-associated gastric cancer. Gastric Cancer., 21(2): 196-203. DOI: https://doi.org/10.1007/s10120-017-0748-z
Abd El Atti R.M., Abu-Zeid R.M. (2017), (2012),CD133 and FGF7: a link between Helicobacter pylori-induced gastritis and gastric carcinoma. Egyptian J Pathology., 32(1): 142-149. DOI: https://doi.org/10.1097/01.XEJ.0000417559.72626.ac
Howard R., AL Diffalha S., Pimiento J., Mejia J., Enderling H., Giuliano A., Coppola D. (2018),CD133 Expression as a Helicobacter pylori-independent Biomarker of Gastric Cancer Progression. Anticancer Research, , 38 (8):4443-4448; DOI: https://doi.org/10.21873/anticanres.12746
Yiming L., Yunshan G., Bo M., Yu Z., Tao W., Gengfang L., Dexian F., Shiqian C., Jianli J., Juan T., Zhinan C. (2015),CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis. Oncotarget., 6(39): 42019-42027. DOI: https://doi.org/10.18632/oncotarget.5714
Yu J.W., Zhang P., Wu J.G., Wu S.H., Li X.Q., Wang S.T., Lu R.Q., Ni X.C., Jiang B.J. (2010),Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma. J Exper Clin Cancer Res., 29: 141. DOI: https://doi.org/10.1186/1756-9966-29-141
Bessede E., Dubus P., Megraud F., Varon C. (2015),Helicobacter pylori infection and stem cells at the origin of gastric cancer. Oncogene, , 34(20): 2547-55. DOI: https://doi.org/10.1038/onc.2014.187
Ferrand J., Lehours P., Schmid-Alliana A., Megraud F., Varon C. (2011),Helicobacter pylori infection of gastrointestinal epithelial cells in vitro induces mesenchymal stem cell migration through an NF-kappaB-dependent pathway. PLoS One., 6(12): e29007. DOI: https://doi.org/10.1371/journal.pone.0029007
Wang T., Ong C.W., Shi J., Srivastava S., Yan B., Cheng C.L., Yong W.P., Chan S.L., Yeoh K.G., Iacopetta B. Salto-Tellez M: (2011),Sequential expression of putative stem cell markers in gastric carcinogenesis. Br J Cancer.,105(5): 658-665. DOI: https://doi.org/10.1038/bjc.2011.287
Jang B.I., Li Y., Graham D.Y., Cen P(2011). The Role of CD44 in the Pathogenesis, Diagnosis, and Therapy of Gastric Cancer. Gut Liver., 5: 397–405. DOI: https://doi.org/10.5009/gnl.2011.5.4.397
Ni T., Wang H., Zhan D., Tao L., Lv M., Wang W., Chu Z., Zhou Z., Sunagawa M., Liu Y. (2021),CD133+/CD166+ human gastric adenocarcinoma cells present the properties of neoplastic stem cells and emerge more malignant features. Life Sci., 15,269:119021. DOI: https://doi.org/10.1016/j.lfs.2021.119021
Jiang Y., He Y., Li H., Li H.N., Zhang L., Hu W., Sun Y.M., Chen F.L., Jin X.M. (2012), Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer. Gastric Cancer. 15(4):440-50. DOI: https://doi.org/10.1007/s10120-012-0140-y
Wakamatsu Y., Sakamoto N., Oo H.Z., Naito Y., Uraoka N., Anami K., Sentani K., Oue N., Yasui W. (2012),Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer. Pathol Int. 62(2):112-9. DOI: https://doi.org/10.1111/j.1440-1827.2011.02760.x
Muraro M.G., Mele V., Däster S., Han J., Heberer M., Cesare Spagnoli G., Iezzi G. (2012),CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines. Stem Cells Transl Med., 1(8):592-603. DOI: https://doi.org/10.5966/sctm.2012-0003
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Israa Alsatar
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
